MedPath

Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.

Not Applicable
Completed
Conditions
Brain Diseases
Interventions
Diagnostic Test: brain PET-MRI with 18F-FDG
Registration Number
NCT05355857
Lead Sponsor
Institut de cancérologie Strasbourg Europe
Brief Summary

With 18F-FDG PET, we have few atlases of normality allowing the realization of objective quantitative analyses. An atlas of normality is a probabilistic atlas of normal FDG uptake from a representative set of brain PET images of healthy subjects. This type of atlas is essential for intra- and inter-individual comparisons.

Accurate quantitative analysis of brain 18F-FDG PET images acquired on a hybrid PET system has been shown to require an institutional normal database for statistical analyzes (Akdemir et al., JNM 2017 and Della Rosa et al Neuroinformatics, 2014).

Detailed Description

This is a prospective, monocentric, non-randomized study, with no direct individual benefit since it involved healthy volunteers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Male or female aged 20 to 50
  • Absence of any history or cardiovascular, neurological or psychiatric deficit
  • Signed the informed consent
Exclusion Criteria
  • Contraindication to the realization of an MRI or PET and to the injection of 18F-FDG
  • People using a pacemaker or insulin pump
  • People wearing a metal prosthesis or an intracerebral clip
  • People with intraocular metal splinters
  • People with a pathology considered incompatible for the production of the atlas according to the investigator
  • Pregnant women and breastfeeding women
  • Subject in period of exclusion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
18F-FDG injectionbrain PET-MRI with 18F-FDGHealth volunteers with 18-F-FDG injection
Primary Outcome Measures
NameTimeMethod
Creation, from a representative set of brain PET-MRI images of healthy subjects, of a probabilistic atlas of normal FDG uptake in healthy volunteers30 minutes after 18F-FDG injection

Evaluation of tracer activity at the cerebral level on the acquisition images

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut de cancérologie Strasbourg Europe

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath